InterVenn Biosciences Adds Glycoproteomic Clinical Testing Panel for Colorectal Cancer and Advanced Adenoma
New results could significantly improve early disease recognition SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--#AI--InterVenn Biosciences today announced it has added a...